%PDF-1.6
%
173 0 obj
<>
endobj
151 0 obj
<>stream
application/pdf
Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer
msumimoto
2019-11-12T10:09:51-05:00
PScript5.dll Version 5.2.2
2019-11-22T10:43:33-08:00
2019-11-22T10:43:33-08:00
Acrobat Distiller 19.0 (Windows)
uuid:953c722a-f9c2-4eb8-99bb-f1433982f83a
uuid:0e270640-1dd2-11b2-0a00-b0000816d4ff
endstream
endobj
169 0 obj
<>
endobj
171 0 obj
<>
endobj
2 0 obj
<>
endobj
30 0 obj
<>
endobj
61 0 obj
<>
endobj
126 0 obj
<>
endobj
125 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
130 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
135 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
139 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
184 0 obj
<>stream
HdRn0+R@* %+#-[+1JVL9N@bg13vd{(c(!+W'pF0«HQo [VwqkV#{X3>3'/SR^zjY%[mI[4sؓ96^S'4LƠF]8L.KPWlM."맪9ֺFM_~K/5D?
V;g[U%d饵zձakVov0I7h=d
ۛZwռQytյQwf&zɸ77in<8qhJB%% KDJEQ 쉲$CDr}
)|:UK߰2lz` WŁ
endstream
endobj
142 0 obj
<>stream
Adobe d
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz m !1AQa"q2#BRbr3$4CS%cs5DT
&6E'dtU7()euFVfvGWgw8HXhx9IYiy*:JZjz ? N*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثThE֫|-,2T~j|ӢA.dPtSUثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]aߜ_+ 0O* PhHS]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثWb]v*UثV ̟ bwq %Ď*